BAJAJ BROKING

Notification
No new Notification messages
Mamata Machinery IPO is Open!
Apply for the Mamata Machinery IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

Torrent Investments To Sell 2.9% Stake In Block Deal.

Listen to our Podcast: Grow your wealth and keep it secure.

0:00 / 0:00

Synopsis:

Torrent Investments to divest up to 2.9% stake in Torrent Pharma through block deals. The floor price set at ₹3,022.71 per share, with a deal value possibly reaching ₹3,000 crore.

Torrent Investments news today

Torrent Investments, a primary promoter of Torrent Pharmaceuticals, is set to sell up to 2.9% of its stake in the company via block deals. The sale floor price has been set at ₹3,022.71 per share, aiming to raise as much as ₹3,000 crore. This transaction will reduce Torrent Investments’ ownership in Torrent Pharma from its current 71.25% stake, as reported for the September quarter.

TORRENT PHARMACEUTICALS L

Trade

3437-32.14 (-0.92 %)

Updated - 20 December 2024
3515.35day high
DAY HIGH
3421.40day low
DAY LOW
358325
VOLUME (BSE)

Structure of the block deal

The block deal involves a base size of 2.4% of Torrent Pharma’s total equity, with an additional upsize option of 0.5%, bringing the potential sale up to 2.9%. The sale price of ₹3,022.71 per share represents the minimum price at which the transaction is likely to be executed. This floor price is designed to provide a pricing benchmark for prospective buyers, ensuring a structured valuation of Torrent Pharma shares throughout the transaction.

Torrent Investments has also agreed to a lock-up period of 120 days, during which it will refrain from selling additional shares. This lock-up term aims to stabilise the market following the sale, limiting further share dilution and providing assurance to investors regarding the promoter’s continued commitment.

Financial implications of the sale

The divestment could raise Torrent Investments an estimated ₹3,000 crore, depending on market reception and share uptake. For Torrent Pharma, the stake reduction may introduce more liquidity into its shares, potentially making the company’s stock more accessible to institutional and retail investors. However, this reduction in promoter holding may affect market perception, especially as the company navigates a competitive pharmaceutical landscape.

Potential market impact and outlook

With Torrent Pharma’s share price currently trading near the floor price, the block deal is likely to create activity within the stock’s trading volumes. The sale by Torrent Investments could influence Torrent Pharma share price, as increased liquidity typically allows for more trading flexibility among investors. However, with a 120-day lock-up in place, investors may view this as a signal of the promoter’s intent to maintain a long-term interest in Torrent Pharma’s growth and stability.

In the long term, this block deal can serve as a strategic opportunity for Torrent Pharma to broaden its shareholder base and improve its market liquidity, potentially bolstering its position in the pharmaceutical sector.

Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.

This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

For All Disclaimers Click Here: https://bit.ly/3Tcsfuc

Share this article: 

Read More Blogs

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text